One study has compared the infiltrating cell types in patients with TDL (acute phase, biopsies, n = 4), in Multiple Sclerosis patients (chronic phase, autopsy, n = 11), in MOG-antibody associated disease (n = 11, biopsies) and ADEM cases (n = 5, biopsies). This evidence concerns the gene MOG and multiple sclerosis.